NewAmsterdam Pharma Company
NAMS
#4537
Rank
NZ$4.37 B
Marketcap
NZ$36.52
Share price
0.85%
Change (1 day)
-46.20%
Change (1 year)

EPS for NewAmsterdam Pharma Company (NAMS)

EPS in 2026 (TTM): NZ-$2.91

According to NewAmsterdam Pharma Company's latest financial reports the company's current EPS (TTM) is NZ-$3.03. In 2025 the company made an earnings per share (EPS) of NZ-$3.12 an increase over its 2024 EPS that were of NZ-$4.64.

EPS history for NewAmsterdam Pharma Company from 2020 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$2.91-6.62%
2025NZ-$3.12-32.81%
2024NZ-$4.6419.07%
2023NZ-$3.9080.67%
2022NZ-$2.16132.27%
2021NZ-$0.93490.94%
2020NZ-$0.16